HGHCX Holdings — The Hartford Healthcare Fund
Data updated: 2026-09-29
HGHCX holds 80 securities. The top 10 make up 47.7% of net assets, led by Eli Lilly & (12.03%) and Johnson & Johnson (6.75%). Health Care (98.8%) and Funds & ETFs (0.9%) are the largest sectors, and 89.6% of the portfolio is in United States. No debt holdings are reported.
Holdings cover 99.35% of net asset value (98.33% of total assets; remainder is cash and receivables). As of July 31, 2026 · N-PORT.
HGHCX Portfolio Holdings
80 holdings of The Hartford Healthcare Fund by percentage of net assets, from the fund's SEC N-PORT filing as of July 31, 2026.
| Holding | Ticker | Sector | % of net assets | Value (USD) |
|---|---|---|---|---|
| Eli Lilly & Co | LLY | Health Care | 12.03% | $92.92M |
| Johnson & Johnson | JNJ | Health Care | 6.75% | $52.11M |
| Merck & Co Inc | MRK | Health Care | 6.00% | $46.31M |
| UnitedHealth Group Inc | UNH | Health Care | 4.74% | $36.57M |
| AbbVie Inc | ABBV | Health Care | 4.21% | $32.54M |
| Elevance Health Inc | ELV | Health Care | 3.00% | $23.16M |
| Intuitive Surgical Inc | ISRG | Health Care | 2.88% | $22.21M |
| CVS Health Corp | CVS | Health Care | 2.84% | $21.93M |
| Vertex Pharmaceuticals Inc | VRTX | Health Care | 2.64% | $20.37M |
| Danaher Corp | DHR | Health Care | 2.57% | $19.86M |
| Edwards Lifesciences Corp | EW | Health Care | 2.48% | $19.17M |
| Cencora Inc | — | Health Care | 2.46% | $19.00M |
| Regeneron Pharmaceuticals Inc | REGN | Health Care | 2.02% | $15.59M |
| HCA Healthcare Inc | HCA | Health Care | 1.88% | $14.51M |
| Boston Scientific Corp | BSX | Health Care | 1.88% | $14.50M |
| Abbott Laboratories | ABT | Health Care | 1.82% | $14.08M |
| Thermo Fisher Scientific Inc | TMO | Health Care | 1.58% | $12.22M |
| Agilent Technologies Inc | A | Health Care | 1.54% | $11.88M |
| Amgen Inc | AMGN | Health Care | 1.39% | $10.72M |
| Biogen Inc | BIIB | Health Care | 1.36% | $10.53M |
| Stryker Corp | SYK | Health Care | 1.24% | $9.54M |
| Gsk PLC | GLAXF | Health Care | 1.17% | $9.01M |
| Medtronic PLC | MDT | Health Care | 1.12% | $8.67M |
| Centene Corp | CNC | Health Care | 1.10% | $8.48M |
| Dexcom Inc | DXCM | Health Care | 1.01% | $7.83M |
| Incyte Corp | INCY | Health Care | 0.95% | $7.30M |
| Cardinal Health Inc | CAH | Health Care | 0.92% | $7.09M |
| United Therapeutics Corp | UTHR | Health Care | 0.87% | $6.74M |
| State Street Navigator Securities Lending Government Money Market Portfolio | — | Funds & ETFs | 0.85% | $6.57M |
| Steris PLC | STE | Health Care | 0.85% | $6.54M |
| Ucb SA | — | Health Care | 0.79% | $6.08M |
| AstraZeneca PLC | AZN | Health Care | 0.79% | $6.07M |
| Ascendis Pharma A/S | ASND | Health Care | 0.75% | $5.83M |
| Bristol-Myers Squibb Co | BMY | Health Care | 0.75% | $5.76M |
| Elanco Animal Health Inc | ELAN | Health Care | 0.73% | $5.67M |
| Cytokinetics Inc | CYTK | Health Care | 0.72% | $5.56M |
| Madrigal Pharmaceuticals Inc | MDGL | Health Care | 0.71% | $5.46M |
| Ionis Pharmaceuticals Inc | IONS | Health Care | 0.70% | $5.39M |
| Galderma Group AG | — | Health Care | 0.68% | $5.24M |
| Alnylam Pharmaceuticals Inc | ALNY | Health Care | 0.66% | $5.11M |
| Revolution Medicines Inc | RVMD | Health Care | 0.65% | $5.04M |
| Protagonist Therapeutics Inc | PTGX | Health Care | 0.62% | $4.80M |
| PTC Therapeutics Inc | PTCT | Health Care | 0.60% | $4.64M |
| HeartFlow Inc | HTFL | Health Care | 0.59% | $4.59M |
| Bridgebio Pharma Inc | BBIO | Health Care | 0.59% | $4.58M |
| Arcus Biosciences Inc | RCUS | Health Care | 0.59% | $4.52M |
| Disc Medicine Inc | IRON | Health Care | 0.56% | $4.30M |
| Argenx SE | ARGX | Health Care | 0.54% | $4.16M |
| Encompass Health Corp | EHC | Health Care | 0.54% | $4.14M |
| Pharvaris NV | PHVS | Health Care | 0.52% | $4.03M |
| Kymera Therapeutics Inc | KYMR | Health Care | 0.52% | $4.00M |
| Celldex Therapeutics Inc | CLDX | Health Care | 0.52% | $3.99M |
| Dianthus Therapeutics Inc | DNTH | Health Care | 0.52% | $3.98M |
| Structure Therapeutics Inc | GPCR | Health Care | 0.49% | $3.81M |
| Scholar Rock Holding Corp | SRRK | Health Care | 0.48% | $3.68M |
| Immunocore Holdings PLC | IMCR | Health Care | 0.48% | $3.67M |
| Adaptive Biotechnologies Corp | ADPT | Health Care | 0.47% | $3.61M |
| Option Care Health Inc | OPCH | Health Care | 0.45% | $3.48M |
| Zenas Biopharma Inc | ZBIO | Health Care | 0.44% | $3.42M |
| Mirum Pharmaceuticals Inc | MIRM | Health Care | 0.43% | $3.31M |
| Vaxcyte Inc | PCVX | Health Care | 0.41% | $3.17M |
| Qiagen NV | QGEN | Health Care | 0.40% | $3.09M |
| Immunome Inc | IMNM | Health Care | 0.40% | $3.09M |
| Fixed, Inc. Clearing Corp.repo | — | Unknown | 0.38% | $2.95M |
| CG oncology Inc | CGON | Health Care | 0.38% | $2.91M |
| Trevi Therapeutics Inc | TRVI | Health Care | 0.37% | $2.84M |
| Inspire Medical Systems Inc | INSP | Health Care | 0.34% | $2.61M |
| Stoke Therapeutics Inc | STOK | Health Care | 0.33% | $2.57M |
| Jiangsu Hengrui Pharmaceuticals Co Ltd | — | Health Care | 0.30% | $2.32M |
| Kailera Therapeutics Inc | KLRA | Health Care | 0.29% | $2.26M |
| Moderna Inc | MRNA | Health Care | 0.29% | $2.23M |
| Definium Therapeutics Inc | DFTX | Health Care | 0.28% | $2.15M |
| Dyne Therapeutics Inc | DYN | Health Care | 0.28% | $2.15M |
| GenFleet Therapeutics Shanghai Inc | — | Health Care | 0.27% | $2.06M |
| Alignment Healthcare Inc | ALHC | Health Care | 0.25% | $1.94M |
| Icon PLC | ICLR | Health Care | 0.25% | $1.94M |
| Avalyn Pharma Inc | AVLN | Health Care | 0.07% | $509.58K |
| Alebund Pharmaceuticals Jiangsu Ltd | — | Health Care | 0.04% | $297.33K |
| Alamar Biosciences Inc | ALMR | Health Care | 0.03% | $230.78K |
| Contra Abiomed, Inc. | — | Unknown | 0.00% | $7.56K |
HGHCX Sector Allocation
The Hartford Healthcare Fund holdings grouped by sector, by share of the portfolio's market value.
| Sector | Weight | Holdings |
|---|---|---|
| Health Care | 98.8% | 77 |
| Funds & ETFs | 0.9% | 1 |
| Unknown | 0.4% | 2 |
HGHCX Country Allocation
Where The Hartford Healthcare Fund's holdings are domiciled, by percentage of net assets (largest 10).
| Country | % of net assets |
|---|---|
| United States | 89.6% |
| United Kingdom | 2.4% |
| Ireland | 2.2% |
| Netherlands | 1.5% |
| Belgium | 0.8% |
| Denmark | 0.8% |
| Switzerland | 0.7% |
| China | 0.6% |
| Cayman Islands | 0.5% |
| Canada | 0.3% |
HGHCX Portfolio Allocation
Asset-class allocation of The Hartford Healthcare Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 98.1% |
| Cash & Equivalents | 1.2% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.